Patents
Patent Title: Human Heme-Regulated Initiation Factor 2.Alpha Kinase
Patent #: 6,562,571
Issue Date: May 13, 2003
Country: United States
Invented By:
Yi-Guang Chen, Athanassios Mantalaris, Takeshi Omasa, Ying-Chuech Tsai, J.H. David Wu
Patent Title: Human Heme-Regulated Initiation Factor 2-Alpha Kinase
Patent #: 7,235,636
Issue Date: Jun 26, 2007
Country: United States
Invented By:
Yi-Guang Chen, Athanassios Mantalaris, Takeshi Omasa, Ying-Chuech Tsai, J.H. David Wu
Publications
Journal Articles
1/1/2019
Zhu R, Xue X, Shen M, Tsai Y, Keng PC, Chen Y, Lee SO, Chen Y. "NF?B and TNF? as individual key molecules associated with the cisplatin-resistance and radioresistance of lung cancer." Experimental cell research.. 2019 Jan 1; 374(1):181-188. Epub 2018 Dec 01.
12/2018
Zhu R, Yang X, Xue X, Shen M, Chen F, Chen X, Tsai Y, Keng PC, Chen Y, Lee SO, Chen Y. "Neuroendocrine differentiation contributes to radioresistance development and metastatic potential increase in non-small cell lung cancer." Biochimica et biophysica acta. Molecular cell research.. 2018 Dec; 1865(12):1878-1890. Epub 2018 Sep 15.
7/2018
Shen M, Chen Y, Xu L, Zhu R, Xue X, Tsai Y, Keng PC, Lee SO, Chen Y. "Increased infiltration of macrophages to radioresistant lung cancer cells contributes to the development of the additional resistance of tumor cells to the cytotoxic effects of NK cells." International journal of oncology.. 2018 Jul; 53(1):317-328. Epub 2018 May 04.
VIEW ALL PUBLICATIONS